The Value of Health Management in Prevention and Treatment of Hyperhomocysteinemia*
Author：YANG Lin, CHEN Li-ling, YYUE Chun-xia, et al.
affiliation：Department of Inpatients , Peking University Shenzhen Hospital, Shenzhen, 518036, China
PDFAbstract
Objective To explore the value of health management in prevention and treatment of hyperhomocysteinemia. Methods The research object was people with MTHFR C677T gene polymorphism, HHcy and abnormal blood lipid had been screened in physical examination who were divided into a control group and a observation group. Two groups took specification of folic acid, vitamin B6 treatment, observation group to implement personalized health promotion interventions. Results Hcy and lipid of the control group was not significantly lower in 6 months after drug treatment. There was no statistically significant difference (P>0.05). Hcy and lipid of the control group was significantly lower in 12 months after drug treatment.There was statistically significant difference (P<0.001,P<0.05). Hcy and lipid of the observation group was significantly lower in personalized health promotion intervention 6 months and 12 months later.There was statistically significant difference (P<0.001,P<0.001). Conclusion Health management can reduce the target population Hcy and lipid level, increase medication compliance, this will help to control the risk factors, prevent the happening of the cerebrovascular disease.
【Keyword】Health Management; HHcy; Abnormal Blood Lipid; Stroke
【Chart number】R972+.6
【Document Identification Number】A
【DOI】10.3969/j.issn.1009-3257.2015.02.016
Journal of Rare Diseases
th22Volume， th 2 Issue
2019Year11Month
Related articles
Editor email：（1）中国CT和MRI杂志：ctmri@vip.163.com；（2）罕少疾病杂志：hs1999@vip.163.com
Contact number：0755-83695203
Our address：
English
简体中文
logged in
Wechat
TouTiao